Key Takeaways
- • Europe deployed €66.2 billion in venture capital investment in 2025, marking a modest recovery after three years of decline, but this represents only 22% of US venture investment despite comparable economy sizes.
- • From 2013 to 2023, EU VC funds raised approximately $130 billion compared to $924 billion raised by US VC funds—a structural funding gap of over $790 billion that reflects systemic competitive disadvantage.
- • No EU company with market capitalization exceeding €100 billion has been established from scratch in the past 50 years, while all six US companies valued above €1 trillion were originally venture-backed, highlighting the innovation and wealth-creation gap.
- • Venture-backed firms represent 50% of US IPOs over the past two decades and undertake approximately 90% of R&D activity among young publicly traded firms, demonstrating venture capital's critical role in driving innovation and economic dynamism.
- • Q2 2026 European VC investment reached $25.6 billion across 1,636 deals, representing Europe's second-highest quarterly total in four years, signaling renewed market sentiment and cautious optimism in the EU financing ecosystem.
Summary
Europe's venture capital market faces a persistent structural challenge that extends far beyond investment volume disparities. While 2025 marked a recovery trajectory with €66.2 billion deployed after a three-year decline, the fundamental imbalance remains stark: European VC investment represents only 22% of US levels despite the two economies operating at roughly comparable scale. This disparity has accumulated over the past decade, with EU VC funds raising just $130 billion between 2013 and 2023 compared to $924 billion raised by US counterparts—a gap that signals deeper institutional and market structure differences rather than cyclical underperformance.
The consequences of this funding gap extend beyond capital availability into competitive positioning and innovation capacity. As highlighted in Mario Draghi's 2024 report on European competitiveness, no EU company with a €100 billion market capitalization has been built from scratch in five decades, while all six US companies valued above €1 trillion were originally venture-backed. This observation underscores a critical reality: venture capital functions as the primary funding mechanism for breakthrough innovation and transformative company creation. In the United States, fully half of all companies that went public over the past two decades—representing the economy's most successful and dynamic enterprises—were venture-backed. These venture-funded firms undertook nearly 90% of R&D activity among young publicly traded firms, meaning that almost all meaningful innovation by young American companies originates from the venture-backed ecosystem.
Recent data suggest cautiously improving market conditions for European venture activity. Q2 2026 European VC investment reached $25.6 billion across 1,636 deals, marking the continent's second-highest quarterly performance in four years. Market sentiment improved notably in the third quarter of 2025, according to European Investment Fund surveys, indicating that investor confidence in financing innovative companies may be stabilizing. The EU's InvestEU programme and broader 2021-2027 Multiannual Financial Framework continue to channel support toward SMEs and mid-cap firms seeking venture capital access.
The strategic importance of addressing Europe's venture capital challenge cannot be overstated for policymakers and institutional investors. Europe possesses 600+ innovation hubs and has generated 424 unicorn companies, demonstrating that entrepreneurial talent and scientific excellence exist on the continent. The issue is not capability or opportunity scarcity, but rather the institutional scaffolding and capital availability required to scale early-stage companies into global market leaders. Proposals from organizations such as Invest Europe focus on EU-backed fund-of-funds structures to support early-stage company growth, suggesting that targeted policy interventions and dedicated capital formation mechanisms remain central to addressing the transatlantic venture capital gap.
The consequences of this funding gap extend beyond capital availability into competitive positioning and innovation capacity. As highlighted in Mario Draghi's 2024 report on European competitiveness, no EU company with a €100 billion market capitalization has been built from scratch in five decades, while all six US companies valued above €1 trillion were originally venture-backed. This observation underscores a critical reality: venture capital functions as the primary funding mechanism for breakthrough innovation and transformative company creation. In the United States, fully half of all companies that went public over the past two decades—representing the economy's most successful and dynamic enterprises—were venture-backed. These venture-funded firms undertook nearly 90% of R&D activity among young publicly traded firms, meaning that almost all meaningful innovation by young American companies originates from the venture-backed ecosystem.
Recent data suggest cautiously improving market conditions for European venture activity. Q2 2026 European VC investment reached $25.6 billion across 1,636 deals, marking the continent's second-highest quarterly performance in four years. Market sentiment improved notably in the third quarter of 2025, according to European Investment Fund surveys, indicating that investor confidence in financing innovative companies may be stabilizing. The EU's InvestEU programme and broader 2021-2027 Multiannual Financial Framework continue to channel support toward SMEs and mid-cap firms seeking venture capital access.
The strategic importance of addressing Europe's venture capital challenge cannot be overstated for policymakers and institutional investors. Europe possesses 600+ innovation hubs and has generated 424 unicorn companies, demonstrating that entrepreneurial talent and scientific excellence exist on the continent. The issue is not capability or opportunity scarcity, but rather the institutional scaffolding and capital availability required to scale early-stage companies into global market leaders. Proposals from organizations such as Invest Europe focus on EU-backed fund-of-funds structures to support early-stage company growth, suggesting that targeted policy interventions and dedicated capital formation mechanisms remain central to addressing the transatlantic venture capital gap.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.